相关实验视频
Updated: Jul 18, 2026

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.0K
在新生儿中最佳使用β-乳酸:基于机器学习的临床决策支持系统
Bo-Hao Tang1, Bu-Fan Yao2, Wei Zhang2
1Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
EBioMedicine
|June 25, 2024
概括
一个新的机器学习临床决策支持系统 (CDSS) 有助于选择最佳的β-乳糖抗生素剂量用于新生儿败血症. 与标准指南相比,这种CDSS提高了目标度的实现.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 人工智能在医学中的应用
背景情况:
- 新生儿败血症的治疗需要精确的β-lactam抗生素剂量,这是临床上具有挑战性的.
- 优化剂量对于有效治疗和最大限度地减少耐药性至关重要.
- 现有的方法可能无法充分解决个体患者的变化.
研究的目的:
- 开发和评估基于机器学习的临床决策支持系统 (CDSS),以优化新生儿败血症中的β-乳酸抗生素剂量.
- 评估CDSS能够预测药理动力学目标的实现的能力.
- 为了将CDSS指导剂量与标准指南建议进行比较.
主要方法:
- 选择了五种关键的β-乳糖抗生素进行分析.
- 使用CatBoost机器学习算法构建了一个CDSS,集成药物,患者,剂量,药理动力学和微生物学的数据.
- 使用现实数据和虚拟试验验验证性能,将CDSS优化的剂量与指导剂量进行比较.
主要成果:
- 对于所有五种药物,CDSS准确地预测一个剂量方案是否能达到药学动力学目标 (fT>MIC),准确度>80.0%.
- 与人口药理动力学 (PopPK) 模型相比,CDSS在准确性,精度,回忆和F1-Score方面显著改善.
- 通过CDSS优化的剂量比指导方针推的剂量增加了达到目标度的平均概率58.2%.
结论:
- 一个基于机器学习的CDSS成功开发,以帮助临床医生选择最佳的β-乳糖抗生素剂量.
- CDSS在改善新生儿败血症治疗结果方面表现有前途.
- 这种工具可以增强儿科传染病管理中的精准医学方法.
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

